ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease causing irreversible lung scarring and loss of pulmonary function. IPF Patients suffer from a high rate of pulmonary infections and acute exacerbations of disease that further contribute to pulmonary decline. Low expression of the ind...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Mucosal Immunol
मुख्य लेखकों: Hrusch, Cara L., Manns, Stephenie T., Bryazka, Dana, Casaos, Joshua, Bonham, Catherine A., Jaffery, Mohammad R., Blaine, Kelly M., Mills, Kathleen A.M., Verhoef, Philip A., Adegunsoye, Ayodeji O., Williams, Jesse W., Tjota, Melissa Y., Moore, Tamson V., Strek, Mary E., Noth, Imre, Sperling, Anne I.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2017
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5681437/
https://ncbi.nlm.nih.gov/pubmed/28488693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mi.2017.42
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन